Mallinckrodt plc, of Dublin, reported presentations at the Spring Clinical Meetings of the National Kidney Foundation in Dallas featuring real-world outcomes with H.P. Acthar Gel (repository corticotropin injection) in the remission of proteinuria due to nephrotic syndrome associated with certain rare by serious kidney disorders.